vs

Side-by-side financial comparison of ESCALADE INC (ESCA) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.

VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $62.6M, roughly 1.2× ESCALADE INC). VIEMED HEALTHCARE, INC. runs the higher net margin — 7.4% vs 5.9%, a 1.5% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs -2.2%). ESCALADE INC produced more free cash flow last quarter ($13.7M vs $9.7M). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs 4.5%).

Escalade Inc is a global sporting goods manufacturer and distributor that offers basketball systems, archery equipment, table tennis gear, game tables, and outdoor recreation accessories. It operates primarily across North America, Europe, and Asia Pacific, serving consumer retail, commercial fitness, and specialty sports segments.

Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.

ESCA vs VMD — Head-to-Head

Bigger by revenue
VMD
VMD
1.2× larger
VMD
$76.2M
$62.6M
ESCA
Growing faster (revenue YoY)
VMD
VMD
+27.7% gap
VMD
25.5%
-2.2%
ESCA
Higher net margin
VMD
VMD
1.5% more per $
VMD
7.4%
5.9%
ESCA
More free cash flow
ESCA
ESCA
$3.9M more FCF
ESCA
$13.7M
$9.7M
VMD
Faster 2-yr revenue CAGR
VMD
VMD
Annualised
VMD
22.7%
4.5%
ESCA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ESCA
ESCA
VMD
VMD
Revenue
$62.6M
$76.2M
Net Profit
$3.7M
$5.6M
Gross Margin
27.7%
57.9%
Operating Margin
8.2%
11.0%
Net Margin
5.9%
7.4%
Revenue YoY
-2.2%
25.5%
Net Profit YoY
37.1%
30.7%
EPS (diluted)
$0.27
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESCA
ESCA
VMD
VMD
Q4 25
$62.6M
$76.2M
Q3 25
$67.8M
$71.9M
Q2 25
$54.3M
$63.1M
Q1 25
$55.5M
$59.1M
Q4 24
$63.9M
$60.7M
Q3 24
$67.7M
$58.0M
Q2 24
$62.5M
$55.0M
Q1 24
$57.3M
$50.6M
Net Profit
ESCA
ESCA
VMD
VMD
Q4 25
$3.7M
$5.6M
Q3 25
$5.6M
$3.5M
Q2 25
$1.8M
$3.2M
Q1 25
$2.6M
$2.6M
Q4 24
$2.7M
$4.3M
Q3 24
$5.7M
$3.9M
Q2 24
$2.8M
$1.5M
Q1 24
$1.8M
$1.6M
Gross Margin
ESCA
ESCA
VMD
VMD
Q4 25
27.7%
57.9%
Q3 25
28.1%
57.5%
Q2 25
24.7%
58.3%
Q1 25
26.7%
56.3%
Q4 24
24.9%
59.5%
Q3 24
24.8%
59.3%
Q2 24
24.2%
59.8%
Q1 24
25.0%
58.9%
Operating Margin
ESCA
ESCA
VMD
VMD
Q4 25
8.2%
11.0%
Q3 25
10.8%
7.8%
Q2 25
4.8%
8.1%
Q1 25
6.6%
6.5%
Q4 24
7.1%
10.6%
Q3 24
11.8%
9.7%
Q2 24
7.1%
6.6%
Q1 24
5.3%
4.4%
Net Margin
ESCA
ESCA
VMD
VMD
Q4 25
5.9%
7.4%
Q3 25
8.2%
4.9%
Q2 25
3.4%
5.0%
Q1 25
4.7%
4.4%
Q4 24
4.2%
7.1%
Q3 24
8.4%
6.7%
Q2 24
4.5%
2.7%
Q1 24
3.1%
3.2%
EPS (diluted)
ESCA
ESCA
VMD
VMD
Q4 25
$0.27
$0.14
Q3 25
$0.40
$0.09
Q2 25
$0.13
$0.08
Q1 25
$0.19
$0.06
Q4 24
$0.20
$0.10
Q3 24
$0.40
$0.10
Q2 24
$0.20
$0.04
Q1 24
$0.13
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESCA
ESCA
VMD
VMD
Cash + ST InvestmentsLiquidity on hand
$13.5M
Total DebtLower is stronger
$18.5M
Stockholders' EquityBook value
$173.2M
$141.5M
Total Assets
$222.1M
$199.2M
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESCA
ESCA
VMD
VMD
Q4 25
$13.5M
Q3 25
$11.1M
Q2 25
$20.0M
Q1 25
$10.2M
Q4 24
$17.5M
Q3 24
$11.3M
Q2 24
$8.8M
Q1 24
$7.3M
Total Debt
ESCA
ESCA
VMD
VMD
Q4 25
$18.5M
Q3 25
Q2 25
Q1 25
Q4 24
$25.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ESCA
ESCA
VMD
VMD
Q4 25
$173.2M
$141.5M
Q3 25
$172.3M
$133.6M
Q2 25
$168.3M
$139.7M
Q1 25
$168.8M
$134.8M
Q4 24
$169.0M
$131.4M
Q3 24
$170.1M
$125.0M
Q2 24
$166.0M
$119.4M
Q1 24
$164.7M
$116.3M
Total Assets
ESCA
ESCA
VMD
VMD
Q4 25
$222.1M
$199.2M
Q3 25
$232.5M
$202.4M
Q2 25
$218.3M
$184.6M
Q1 25
$222.1M
$178.1M
Q4 24
$226.3M
$177.1M
Q3 24
$244.9M
$169.5M
Q2 24
$243.1M
$163.9M
Q1 24
$256.3M
$154.9M
Debt / Equity
ESCA
ESCA
VMD
VMD
Q4 25
0.11×
Q3 25
Q2 25
Q1 25
Q4 24
0.15×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESCA
ESCA
VMD
VMD
Operating Cash FlowLast quarter
$14.9M
$18.4M
Free Cash FlowOCF − Capex
$13.7M
$9.7M
FCF MarginFCF / Revenue
21.8%
12.7%
Capex IntensityCapex / Revenue
2.0%
11.5%
Cash ConversionOCF / Net Profit
4.02×
3.27×
TTM Free Cash FlowTrailing 4 quarters
$28.5M
$11.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESCA
ESCA
VMD
VMD
Q4 25
$14.9M
$18.4M
Q3 25
$-965.0K
$18.4M
Q2 25
$13.3M
$12.3M
Q1 25
$3.8M
$2.9M
Q4 24
$12.3M
$15.0M
Q3 24
$10.5M
$12.7M
Q2 24
$13.3M
$10.2M
Q1 24
$7.0K
$1.2M
Free Cash Flow
ESCA
ESCA
VMD
VMD
Q4 25
$13.7M
$9.7M
Q3 25
$-1.3M
$10.7M
Q2 25
$12.9M
$4.1M
Q1 25
$3.2M
$-12.6M
Q4 24
$11.7M
$3.2M
Q3 24
$10.2M
$1.7M
Q2 24
$12.5M
$1.2M
Q1 24
$-350.0K
$-4.8M
FCF Margin
ESCA
ESCA
VMD
VMD
Q4 25
21.8%
12.7%
Q3 25
-1.9%
14.9%
Q2 25
23.7%
6.5%
Q1 25
5.9%
-21.4%
Q4 24
18.4%
5.2%
Q3 24
15.0%
3.0%
Q2 24
20.0%
2.3%
Q1 24
-0.6%
-9.5%
Capex Intensity
ESCA
ESCA
VMD
VMD
Q4 25
2.0%
11.5%
Q3 25
0.4%
10.6%
Q2 25
0.8%
12.9%
Q1 25
1.0%
26.2%
Q4 24
0.9%
19.5%
Q3 24
0.5%
19.0%
Q2 24
1.3%
16.3%
Q1 24
0.6%
11.9%
Cash Conversion
ESCA
ESCA
VMD
VMD
Q4 25
4.02×
3.27×
Q3 25
-0.17×
5.23×
Q2 25
7.28×
3.88×
Q1 25
1.45×
1.09×
Q4 24
4.55×
3.47×
Q3 24
1.85×
3.29×
Q2 24
4.67×
6.94×
Q1 24
0.00×
0.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons